Saturday, June 19, 2021

Advertising     Publishers

Home Science News Common diabetes drug shows promise as treatment for COVID-19 lung inflammation --...

Common diabetes drug shows promise as treatment for COVID-19 lung inflammation — ScienceDaily


Metformin is a widely prescribed blood sugar-lowering drug. It is often used as an early therapy (in combination with diet and lifestyle changes) for type 2 diabetes, which afflicts more than 34 million Americans.

Metformin works by lowering glucose production in the liver, reducing blood sugar…



Click here to view the original article.

- Advertisment -
- Advertisment -

Recently Viewed

You might also like ...

Article feature image
NASA needs your help naming the dummy it’s sending to the moon – CNET
Article feature image
What caused the ‘Great Dimming’ of giant star Betelgeuse? Finally, an answer – CNET